We expected that the treatment of rhIL-21 in the co-culture of HIF-1α-expressed HCC SK-Hep1 cells and NK-92 cells could enhance the effector function of NK cells against cancer cells compared to the treatment of IL-6 antibody alone. The gene discussed is HIF1A; the disease is cancer.